The FDA on Tuesday issued a rule approving the sale of over-the-counter hearing aids. The move could save consumers thousands of dollars and also opens the door for increased competition. In anticipation of Agency approval, companies such as Bose have been developing new products that will not only be less expensive but perhaps also more

FDA’s user fee programs for prescription and generic drugs, medical devices, and biosimilars must be reauthorized by September 30, 2022. On June 8, 2022, the House passed its version of the Food and Drug Amendments of 2022, and on June 14, 2022, the Senate HELP Committee marked up the similarly situated Food and Drug Administration